L

Lipocine
D

LPCN

4.91000
USD
0.05
(1.03%)
مغلق
حجم التداول
494
الربح لكل سهم
-2
العائد الربحي
-
P/E
-7
حجم السوق
26,258,385
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ACST
    0
    (0%)
    0.000000 USD
    A
    AMRN
    -0.03370
    (-7.04%)
    0.44500 USD
    A
    AXSM
    -3.970
    (-4.37%)
    86.870 USD
    E
    EVOK
    -0.04000
    (-0.79%)
    5.05000 USD
    F
    FGEN
    0.06830
    (16.77%)
    0.47550 USD
    V
    VKTX
    0.045
    (0.11%)
    42.315 USD
    المزيد
الأخبار
المقالات

العنوان: Lipocine

القطاع: Healthcare
الصناعة: Biotechnology
Lipocine Inc is a clinical-stage biopharmaceutical company. It is focused on oral drug delivery technology for the development of pharmaceutical products focusing on metabolic and endocrine disorders. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, LPCN 1148, and LPCN 1107. The Company has single reportable segment being, research and development for the delivery of drugs using its proprietary delivery technology.